Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Dissociation of corticotropin-releasing factor receptor subtype involvement in sensitivity to locomotor effects of methamphetamine and cocaine.

Giardino WJ, Mark GP, Stenzel-Poore MP, Ryabinin AE.

Psychopharmacology (Berl). 2012 Feb;219(4):1055-63. doi: 10.1007/s00213-011-2433-y. Epub 2011 Aug 11.

2.

Dissection of corticotropin-releasing factor system involvement in locomotor sensitivity to methamphetamine.

Giardino WJ, Pastor R, Anacker AM, Spangler E, Cote DM, Li J, Stenzel-Poore MP, Phillips TJ, Ryabinin AE.

Genes Brain Behav. 2011 Feb;10(1):78-89. doi: 10.1111/j.1601-183X.2010.00641.x. Epub 2010 Sep 30.

3.

Neuropeptide S reinstates cocaine-seeking behavior and increases locomotor activity through corticotropin-releasing factor receptor 1 in mice.

Pañeda C, Huitron-Resendiz S, Frago LM, Chowen JA, Picetti R, de Lecea L, Roberts AJ.

J Neurosci. 2009 Apr 1;29(13):4155-61. doi: 10.1523/JNEUROSCI.5256-08.2009.

4.
5.

Evaluation of a pharmacokinetic hypothesis for reduced locomotor stimulation from methamphetamine and cocaine in adolescent versus adult male C57BL/6J mice.

Zombeck JA, Gupta T, Rhodes JS.

Psychopharmacology (Berl). 2009 Jan;201(4):589-99. doi: 10.1007/s00213-008-1327-0. Epub 2008 Sep 17.

PMID:
18797848
6.

Role of corticotropin-releasing factor and corticosterone in behavioral sensitization to ethanol.

Pastor R, Reed C, Meyer PJ, McKinnon C, Ryabinin AE, Phillips TJ.

J Pharmacol Exp Ther. 2012 May;341(2):455-63. doi: 10.1124/jpet.111.190595. Epub 2012 Feb 14.

7.

Sensitivity to psychostimulants in mice bred for high and low stimulation to methamphetamine.

Kamens HM, Burkhart-Kasch S, McKinnon CS, Li N, Reed C, Phillips TJ.

Genes Brain Behav. 2005 Mar;4(2):110-25.

8.

Prevention of social stress-escalated cocaine self-administration by CRF-R1 antagonist in the rat VTA.

Boyson CO, Miguel TT, Quadros IM, Debold JF, Miczek KA.

Psychopharmacology (Berl). 2011 Nov;218(1):257-69. doi: 10.1007/s00213-011-2266-8. Epub 2011 Apr 6.

9.
10.

Complicated interaction between psychostimulants and morphine in expression of phenotype of behavior in the dopaminergic system of BALB/c mice.

Ito S, Mori T, Namiki M, Suzuki T, Sawaguchi T.

J Pharmacol Sci. 2007 Dec;105(4):326-33. Epub 2007 Dec 1.

11.

Combined effects of psychostimulants and morphine on locomotor activity in mice.

Mori T, Ito S, Narita M, Suzuki T, Sawaguchi T.

J Pharmacol Sci. 2004 Dec;96(4):450-8. Epub 2004 Dec 10.

12.

A role for neuronal nicotinic acetylcholine receptors in ethanol-induced stimulation, but not cocaine- or methamphetamine-induced stimulation.

Kamens HM, Phillips TJ.

Psychopharmacology (Berl). 2008 Feb;196(3):377-87. Epub 2007 Oct 16.

PMID:
17938890
13.

Patterns of neural activity associated with differential acute locomotor stimulation to cocaine and methamphetamine in adolescent versus adult male C57BL/6J mice.

Zombeck JA, Lewicki AD, Patel K, Gupta T, Rhodes JS.

Neuroscience. 2010 Feb 17;165(4):1087-99. doi: 10.1016/j.neuroscience.2009.11.038. Epub 2009 Nov 22.

14.

Prior, repeated exposure to cocaine potentiates locomotor responsivity to central injections of corticotropin-releasing factor (CRF) in rats.

Erb S, Funk D, Lê AD.

Psychopharmacology (Berl). 2003 Dec;170(4):383-9. Epub 2003 Aug 30.

PMID:
12955298
15.

Unique genetic factors influence sensitivity to the rewarding and aversive effects of methamphetamine versus cocaine.

Gubner NR, Reed C, McKinnon CS, Phillips TJ.

Behav Brain Res. 2013 Nov 1;256:420-7. doi: 10.1016/j.bbr.2013.08.035. Epub 2013 Aug 28.

16.

Differential effects of trihexyphenidyl on place preference conditioning and locomotor stimulant activity of cocaine and methamphetamine.

Shimosato K, Watanabe S, Kitayama S.

Naunyn Schmiedebergs Arch Pharmacol. 2001 Jul;364(1):74-80.

PMID:
11485042
18.

Teneurin C-terminal associated peptide-1 blocks the effects of corticotropin-releasing factor on reinstatement of cocaine seeking and on cocaine-induced behavioural sensitization.

Kupferschmidt DA, Lovejoy DA, Rotzinger S, Erb S.

Br J Pharmacol. 2011 Feb;162(3):574-83. doi: 10.1111/j.1476-5381.2010.01055.x.

19.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk